approval
saveKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
community read0 votes
Sponsor: GENENTECH. Form: VIAL. Route: SINGLE-USE
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalMar 26, 2026 · 239d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalFeb 2, 2022 · 1752d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalSep 27, 2020 · 2245d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalMay 3, 2019 · 2758d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalDec 18, 2018 · 2894d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalSep 20, 2018 · 2983d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalJul 25, 2016 · 3770d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalApr 28, 2016 · 3858d ago
comments(0)
5-min edit window · permanent after that